BioCentury
ARTICLE | Company News

Icagen deal

September 6, 1994 7:00 AM UTC

Under the initial agreement, ICAgen received exclusive rights to screen SPHX's combinatorial chemistry libraries for lead compounds that interact with ion channel targets under investigation by ICAgen.

The new agreement gives ICAgen exclusive rights to screen all compound libraries developed using Lilly's chemical library technologies against chloride, potassium and water channels, as well as non-exclusive rights to screen these libraries against certain other types of ion channels. ...